Hepatitis C and history of FVIII inhibitor development in a long‐term cohort of Brazilian patients with haemophilia A

作者: Marina Lobato Martins , Daniel Gonçalves Chaves , Maria Clara Fernandes Silva‐Malta , Eduarda Bolina‐Santos , Edel Figueiredo Barbosa‐Stancioli

DOI: 10.1111/HAE.13944

关键词: CohortMedicineFviii inhibitorHaemophilia AMEDLINEHepatitis CPediatrics

摘要:

参考文章(9)
David Green, Klaus Lechner, A survey of 215 non-hemophilic patients with inhibitors to Factor VIII. Thrombosis and Haemostasis. ,vol. 45, pp. 200- 203 ,(1981) , 10.1055/S-0038-1650169
P. KNOEBL, P. MARCO, F. BAUDO, P. COLLINS, A. HUTH-KÜHNE, L. NEMES, F. PELLEGRINI, L. TENGBORN, H. LÉVESQUE, , Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2) Journal of Thrombosis and Haemostasis. ,vol. 10, pp. 622- 631 ,(2012) , 10.1111/J.1538-7836.2012.04654.X
M. Algiman, G. Dietrich, U. E. Nydegger, D. Boieldieu, Y. Sultan, M. D. Kazatchkine, Natural antibodies to factor VIII (anti-hemophilic factor) in healthy individuals. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 89, pp. 3795- 3799 ,(1992) , 10.1073/PNAS.89.9.3795
Marilza Campos‐de‐Magalhães, Carlos Eduardo Brandão‐Mello, Maria Lúcia Elias Pires, Maria Cecília da Fonseca Salgado, Selma Barcelo de Brito, Adilson José de Almeida, Factor VIII and IX deficiencies related to acquired inhibitors in a patient with chronic hepatitis C virus infection receiving treatment with pegylated interferon plus ribavirin. Hematology. ,vol. 16, pp. 80- 85 ,(2011) , 10.1179/102453311X12902908412156
Charles R.M. Hay, Ben Palmer, Elizabeth Chalmers, Ri Liesner, Rhona Maclean, Savita Rangarajan, Michael Williams, Peter W. Collins, , Incidence of factor VIII inhibitors throughout life in severe hemophilia A in the United Kingdom Blood. ,vol. 117, pp. 6367- 6370 ,(2011) , 10.1182/BLOOD-2010-09-308668
I. PLUG, J. G. VAN DER BOM, M. PETERS, E. P. MAUSER-BUNSCHOTEN, A. DE GOEDE-BOLDER, L. HEIJNEN, C. SMIT, J. WILLEMSE, F. R. ROSENDAAL, Mortality and causes of death in patients with hemophilia, 1992-2001: a prospective cohort study. Journal of Thrombosis and Haemostasis. ,vol. 4, pp. 510- 516 ,(2006) , 10.1111/J.1538-7836.2006.01808.X
Arkadiusz Urbanowicz, Radosław Zagożdżon, Michał Ciszek, Modulation of the Immune System in Chronic Hepatitis C and During Antiviral Interferon-Free Therapy. Archivum Immunologiae Et Therapiae Experimentalis. ,vol. 67, pp. 79- 88 ,(2019) , 10.1007/S00005-018-0532-8
Ricardo Andrade Carmo, Marina Lobato Martins, Daniel Gonçalves Chaves, Lorenza Nogueira Campos Dezanet, Prevalence and risk factors associated with hepatitis C among Brazilian male patients with haemophilia: A long-term follow-up. Haemophilia. ,vol. 25, pp. 447- 455 ,(2019) , 10.1111/HAE.13728